美股市場個股詳情
BIIB 渤健公司
- 158.010
- +2.010+1.29%
收盤價 11/21 16:00 (美東)
- 158.510
- +0.500+0.32%
盤後 20:01 (美東)
230.25億總市值14.29市盈率TTM
159.100最高價154.740最低價188.61萬股成交量157.170今開156.000昨收2.97億成交額1.30%換手率19.83市盈率(靜)1.46億總股本268.29552周最高1.41市淨率229.48億流通值153.62052周最低--股息TTM1.45億流通股480.180歷史最高--股息率TTM2.80%振幅2.625歷史最低157.546平均價1股每手
關於渤健公司公司
生物基因公司是一家生物製藥公司，從事神經和神經退行性疾病的發現、開發和提供治療。其產品包括治療多發性硬化症的TECFIDERA、VUMERITY、AVONEX、PLEGRIDY、TYSABRI和FAMPYRA，治療SMA的SPINRAZA，治療阿爾茨海默病的ADUHELM和治療嚴重斑塊性銀屑病的FUMADERM。
公司介紹
公司代碼BIIB
公司名稱渤健公司
上市日期1991/09/17
發行價格15.00
成立日期1978
CEOMr. Christopher A. Viehbacher
所屬市場納斯達克
員工數量7570
年結日12-31
公司地址225 Binney Street
城市Cambridge
省份麻塞諸塞州
國家美國
郵編02142
電話1-617-679-2000
董事高管
- 姓名
- 職務
- 年薪
- Christopher A. Viehbacher
- Director, President and Chief Executive Officer
- 406.99萬
- Robin C. Kramer
- Senior Vice President and Chief Accounting Officer
- --
- Michael R. Mcdonnell
- Executive Vice President and Chief Financial Officer
- 716.76萬
- Susan H. Alexander
- Executive Vice President and Chief Legal Officer
- 670.39萬
- Dr. Ginger Gregory, PhD
- Executive Vice President and Chief Human Resources Officer
- --
- Nicole Murphy
- Executive Vice President, Pharmaceutical Operations and Technology
- 571.43萬
- Dr. Jane Grogan, PhD
- Executive Vice President, Head of Research
- --
- Rachid Izzar
- Executive Vice President, Global Product Strategy and Commercialization
- 544.78萬
- Dr. Priya Singhal, M.D.,M.P.H.
- Executive Vice President and Head of Development
- --
- Adam Keeney, PhD
- Executive Vice President, Head of Corporate Development
- --
- Caroline D. Dorsa
- Chairman of the Board
- 64.61萬
- Professor Menelas Pangalos, PhD
- Independent Director
- --
- Jesus B. Mantas
- Independent Director
- 43.32萬
- Dr. Eric K. Rowinsky,M.D.
- Independent Director
- 41.80萬
- Monish D. Patolawala
- Independent Director
- --
- Dr. Stephen A. Sherwin, M.D.
- Independent Director
- 43.53萬
- Dr. Lloyd Minor
- Independent Director
- --
- William A. Hawkins, III
- Independent Director
- 42.57萬
- Susan Langer
- Independent Director
- 33.45萬
- Dr. Maria C. Freire, PhD
- Independent Director
- 41.29萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據
